HK1014627A1 - A solid phase process for synthesizing thymosin alpha 1 - Google Patents

A solid phase process for synthesizing thymosin alpha 1

Info

Publication number
HK1014627A1
HK1014627A1 HK98105713A HK98105713A HK1014627A1 HK 1014627 A1 HK1014627 A1 HK 1014627A1 HK 98105713 A HK98105713 A HK 98105713A HK 98105713 A HK98105713 A HK 98105713A HK 1014627 A1 HK1014627 A1 HK 1014627A1
Authority
HK
Hong Kong
Prior art keywords
moz
alpha
amino acids
trifluoroacetic acid
thymosin alpha
Prior art date
Application number
HK98105713A
Other languages
English (en)
Inventor
Su Sun Wang
Original Assignee
Alpha 1 Biomedicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpha 1 Biomedicals Inc filed Critical Alpha 1 Biomedicals Inc
Publication of HK1014627A1 publication Critical patent/HK1014627A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • C07K1/063—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for alpha-amino functions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/042—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers characterised by the nature of the carrier
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57581—Thymosin; Related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK98105713A 1988-05-10 1998-06-19 A solid phase process for synthesizing thymosin alpha 1 HK1014627A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19234988A 1988-05-10 1988-05-10

Publications (1)

Publication Number Publication Date
HK1014627A1 true HK1014627A1 (en) 1999-09-30

Family

ID=22709272

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98105713A HK1014627A1 (en) 1988-05-10 1998-06-19 A solid phase process for synthesizing thymosin alpha 1

Country Status (7)

Country Link
US (2) US5610272A (de)
EP (1) EP0341935B1 (de)
JP (1) JP2812709B2 (de)
KR (1) KR970010922B1 (de)
AT (1) ATE136551T1 (de)
DE (1) DE68926178T2 (de)
HK (1) HK1014627A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68926178T2 (de) * 1988-05-10 1996-11-28 Alpha 1 Biomedicals Inc Festphase-Verfahren zur Gewinnung von Thymosin-alpha-1
US6262230B1 (en) * 1994-01-28 2001-07-17 Sciclone Pharmaceuticals Inc. Analogs of thymosin α1
US6921751B1 (en) * 1998-05-20 2005-07-26 Erasmus Universiteit Rotterdam Immunoregulator
US8680059B2 (en) * 1998-05-20 2014-03-25 Biotempt B.V. Oligopeptide acetate and formulations thereof
US20040202645A1 (en) * 2003-04-08 2004-10-14 Khan Nisar Ahmed Administration of gene-regulatory peptides
US20030220258A1 (en) * 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
US6844315B2 (en) 1998-05-20 2005-01-18 Erasmus Universiteit Rotterdam Immunoregulator
US20050227925A1 (en) * 2004-04-08 2005-10-13 Robbert Benner Compositions capable of reducing elevated blood urea concentration
US20050037430A1 (en) * 2000-03-29 2005-02-17 Biotempt B.V. Methods and uses for protein breakdown products
EP1300418A1 (de) * 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Genregulation durch Oligopeptide
US7358330B2 (en) * 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
US20050020495A1 (en) * 2001-10-24 2005-01-27 Martins Eduardo Bruno Guimaraes Antiretroviral compositions comprising thymosin alpha peptides and protease inhibitors
US20080318871A1 (en) * 2001-12-21 2008-12-25 Khan Nisar A Treatment of neurological disorders
US20030220257A1 (en) * 2001-12-21 2003-11-27 Robbert Benner Treatment of trauma
US7560433B2 (en) 2001-12-21 2009-07-14 Biotempt B.V. Treatment of multiple sclerosis (MS)
US7786084B2 (en) * 2001-12-21 2010-08-31 Biotempt B.V. Treatment of burns
US20080242837A1 (en) * 2001-12-21 2008-10-02 Khan Nisar A Peptide compositions
US20090227505A1 (en) * 2004-01-07 2009-09-10 Biotempt B.V. Methods and uses for protein breakdown products
AU2006243344B2 (en) * 2005-05-04 2011-04-21 Lonza Ag Solid phase bound thymosin alpha-1 and its synthesis
CN101217971B (zh) * 2005-07-05 2011-11-09 比奥滕普特公司 肿瘤的治疗
EP1864692A1 (de) * 2006-06-07 2007-12-12 Biotempt B.V. Verwendung von peptiden zum Schutz von Strahlenschäden
ES2288118B1 (es) 2006-05-10 2008-11-01 Bcn Peptides, S.A. Procedimiento para sintetizar timosinas.
WO2008100140A1 (en) * 2007-02-12 2008-08-21 Biotempt B.V. Treatment of trauma hemorrhage with short oligopeptides
US20080217002A1 (en) * 2007-03-07 2008-09-11 Floyd Randolph Simonds Sand control screen having a micro-perforated filtration layer
CN101104638B (zh) * 2007-06-18 2011-06-01 苏州天马医药集团天吉生物制药有限公司 胸腺素α1的固相合成工艺
CN103980357B (zh) * 2013-09-10 2017-07-07 杭州阿诺生物医药科技股份有限公司 一种合成胸腺法新的方法
CN108218980B (zh) * 2016-12-21 2020-12-08 鲁南制药集团股份有限公司 一种胸腺法新的合成方法
CN109748954B (zh) * 2017-11-06 2022-03-01 正大天晴药业集团股份有限公司 一种地加瑞克的纯化方法
JPWO2022196797A1 (de) 2021-03-19 2022-09-22

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4207311A (en) * 1977-07-18 1980-06-10 The Salk Institute For Biological Studies Peptides having analgesic and thermoregulative properties
US4148788A (en) * 1978-01-23 1979-04-10 Hoffmann-La Roche Inc. Synthesis of thymosin α1
JPS54148722A (en) * 1978-05-12 1979-11-21 Takeda Chem Ind Ltd Nonapeptide and its preparation
US4215112A (en) * 1979-03-14 1980-07-29 Ortho Pharmaceutical Corporation Tripeptides and methods
US4244946A (en) * 1979-06-11 1981-01-13 The Salk Institute For Biological Studies Water-soluble peptides affecting gonadal function
US4382922A (en) * 1980-08-29 1983-05-10 The Salk Institute For Biological Studies Peptides affecting gonadal function
US4361673A (en) * 1980-09-19 1982-11-30 American Home Products Corporation Polypeptide compositions
US4406832A (en) * 1981-09-03 1983-09-27 Mallinckrodt, Inc. Peptide-type substrates useful in the quantitative determination of endotoxin
US4507230A (en) * 1982-05-12 1985-03-26 Research Corporation Peptide synthesis reagents and method of use
US4855407A (en) * 1985-04-11 1989-08-08 Alpha-1 Biomedicals, Inc. Solid phase process for synthesizing peptides
DE68926178T2 (de) * 1988-05-10 1996-11-28 Alpha 1 Biomedicals Inc Festphase-Verfahren zur Gewinnung von Thymosin-alpha-1

Also Published As

Publication number Publication date
US5610272A (en) 1997-03-11
KR970010922B1 (ko) 1997-07-02
DE68926178T2 (de) 1996-11-28
DE68926178D1 (de) 1996-05-15
EP0341935A3 (de) 1991-05-22
ATE136551T1 (de) 1996-04-15
EP0341935B1 (de) 1996-04-10
KR890017267A (ko) 1989-12-15
JPH0236197A (ja) 1990-02-06
JP2812709B2 (ja) 1998-10-22
US5856440A (en) 1999-01-05
EP0341935A2 (de) 1989-11-15

Similar Documents

Publication Publication Date Title
HK1014627A1 (en) A solid phase process for synthesizing thymosin alpha 1
US4351762A (en) Rapid, quantitative peptide synthesis using mixed anhydrides
JP2733591B2 (ja) 固相ペプチド合成法
YU45907B (sh) Postupak za dobijanje novih grf analoga
AU574064B2 (en) Growth hormone releasing factor analogues
AU602228B2 (en) (n-alpha-acyl, 8-glycine, des-19-leucine)-calcitonin
DE69121742D1 (de) Verfahren zur Herstellung von Somatotropinmonomeren in reiner Form
Schwartz et al. Synthesis of des (tetrapeptide B1-4) and des (pentapeptide B1-5) human insulin. Two biologically active analogs
FR2557114A1 (fr) Nouveaux derives de la gonadoliberine, procede pour leur preparation et compositions pharmaceutiques les contenant
Kiso et al. A FLUORIDE ION DEPROTECTION STRATEGY IN PEPTIDE SYNTHESIS. COMBINATION WITH SELECTIVE DEPROTECTION USING THE DILUTE METHANESULFONIC ACID OF α-AMINO PROTECTING GROUPS
US6448031B1 (en) Process for producing LH-RH derivatives
Fridkin et al. Polymeric reagent synthesis of luteinizing hormone-releasing hormone: Comparison with a conventional stepwise preparation
Tjoeng et al. 4-(2-Chloropropionyl) phenylacetoxy-polyethylene glycol: a new photolabile support for liquid phase peptide synthesis
EP0056274B1 (de) Indol-Derivate und Verfahren zur Herstellung von Peptiden
Heavner et al. Cleavage of peptides from benzhydrylamine resins using trifluoromethanesulfonic acid
JP2777193B2 (ja) ペプチドの製造方法
Kiso et al. N in-Diphenylphosphinothioyltryptophan, a useful derivative for peptide synthesis by the methanesulphonic acid–thioanisole system and fluoride ion deprotection methods
RU2091389C1 (ru) Пептид, обладающий иммуномодулирующей активностью
Katakai et al. Synthesis of oligopeptides having alternate L-leucyl and L-methionyl residues
JPS57108053A (en) Tripeptide and its derivative
Hazum et al. Synthesis, biological activity and resistance to enzymic degradation of luteinizing hormone--releasing hormone analogues modified at position 7.
KR840000054B1 (ko) 티모신 α₁의 제조방법
Olma et al. Synthesis and binding properties of deltorphin I analogues containing (R) and (S)-α-hydroxymethylnaphtylalanine.
TENO et al. Amino Acids and Peptides. XIV. Synthesis and Biological Activity of Three S-Peptide Analogues of Bovine Pancreatic Ribonuclease A (RNase A)
Schaaper et al. Synthesis of vasoactive intestinal peptide (VIP) via the mixed anhydride method

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20090504